U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06714227) titled 'Genetics of Prostate Cancer in Young Patients' on Nov. 28. Brief Summary: The aim of the st... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713720) titled 'Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy' on Nov. 21. Brief ... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713694) titled 'The Impact of Culture in Cognitive Behavior Therapy (CBT) for Anxiety, with Inflammatory Bow... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713031) titled 'Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures' on Nov. 16. B... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713746) titled 'Growth Differentiation Factor 15 in ICU Acquired Muscle Weakness' on Nov. 29, 2021. Brief S... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713174) titled 'Interleukin 8 And10 Levels Changes in Teeth with Necrotic Pulp and Apical Periodontitis' on ... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06714266) titled 'Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713291) titled 'Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femora... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713876) titled 'Long-term Outcomes of Patients Undergoing ECMO-assisted PCI' on Nov. 28. Brief Summary: Evi... Read More
U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06712927) titled 'Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic... Read More